Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
INDV Transcript
Indivior Pharmaceuticals, Inc. (INDV) Q1 2026 Earnings Call Transcript
Positive4-30
Despite the absence of strategic updates, the financial performance is strong with a 10% revenue increase, improved gross margins, and a 25% rise in operating income. The positive EPS growth and increased cash flow from operations further support a positive sentiment. The market cap indicates a moderate reaction, leading to a predicted stock price increase of 2% to 8% over the next two weeks.
Indivior Pharmaceuticals, Inc. (INDV) Q4 2025 Earnings Call Transcript
Positive2-26
Indivior's earnings call highlights strong financial performance, with SUBLOCADE revenue growth and improved cash flow, despite a significant DOJ payment. Optimistic guidance for 2025 and a focus on shareholder returns through share repurchases are positive indicators. While management avoided some specifics, the overall sentiment in the Q&A was positive, with analysts recognizing growth potential in LAI buprenorphine penetration. The company's strategic focus on new therapeutic areas and operational efficiencies further supports a positive outlook. Given the market cap, the stock is likely to see a positive reaction, estimated between 2% to 8%.
Indivior PLC (INDV) Q3 2025 Earnings Call Transcript
Positive10-30
The company has raised its financial guidance for 2025, indicating strong performance and growth expectations. The Q&A section reveals effective cost management and strategic focus on SUBLOCADE's growth, with positive indicators such as increased dispense growth and prescriber base. Despite some management evasiveness, the overall sentiment is positive, supported by strong financial metrics and optimistic guidance.
Indivior PLC (INDV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Neutral9-8
INDV Slides
INDV Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
